morphosys ag (MOR:Xetra)
Earnings & Estimates Summary - MORPHOSYS AG (MOR)
2013 revenues at Morphosys AG totaled €78.0M EUR, while annual earnings equaled €0.30 per share.
Quarterly Earnings & Estimates - MORPHOSYS AG (MOR)
Morphosys AG's Quarterly Earnings
Morphosys AG reported 2nd quarter 2014 losses of €0.02 per share on 07/30/2014.
Annual Earnings & Estimates - MORPHOSYS AG (MOR)
Morphosys AG's Annual Earnings
Morphosys AG reported annual 2013 earnings of €0.30 per share on 03/2/2014.
Quarterly Revenues - MORPHOSYS AG (MOR)
Morphosys AG's Quarterly Revenues
Morphosys AG had 2nd quarter 2014 revenues of €14.6M EUR. This missed the €14.7M EUR consensus estimate of the 2 analysts following the company. This was -53.4% below the prior year's 2nd quarter results.
Annual Revenues - MORPHOSYS AG (MOR)
Morphosys AG's Annual Revenues
Morphosys AG had revenues for the full year 2013 of €78.0M EUR. This was 12.1% above the prior year's results.
|Ablynx NV||€10.03 EUR||+0.231|
|Genmab A/S||kr560.00 DKK||+14.50|
|ImmunoGen Inc||$8.86 USD||-1.10|
|Intrexon Corp||$40.86 USD||-3.24|
|XOMA Corp||$3.45 USD||-0.15|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|